By Kyle Morris
IQ-AI Ltd. said Tuesday that a recent study published in the American Journal of Neuroradiology concluded that a subsidiary's imaging technology could identify tumors.
The U.K. medical-software and services company said Imaging Biometrics LLC's DSC MRI Perfusion could reliably distinguish between progressive tumor and radiation necrosis non-tumor tissue.
Shares in the company at 1433 GMT were up 0.40 pence, or 9.2%, at 4.75 pence.
Write to Kyle Morris at kyle.morris@dowjones.com
Debian Security Advisory 5664-1 – Torchsec April 18, 2024 -----BEGIN PGP SIGNED MESSAGE-----Hash: SHA512- -------------------------------------------------------------------------Debian Security Advisory DSA-5664-1 security@debian.orghttps://www.debian.org/security/… (9)
Google Sues App Developers Over Fake Crypto… April 8, 2024 Apr 08, 2024NewsroomInvestment Scam / Mobile Security Google has filed… (8)Red Hat Security Advisory 2024-1687-03 – Torchsec April 9, 2024 The following advisory data is extracted from:https://access.redhat.com/security/data/csaf/v2/advisories/2024/rhsa-2024_1687.jsonRed Hat officially shut… (8)Daily Expense Manager 1.0 SQL Injection – Torchsec April 8, 2024 # Exploit Title: Daily Expense Manager 1.0 - 'term' SQLi#… (7)
Gloss